ACI-24.060 Anti-Abeta Vaccine

May 13
3 min read

$2.1 Billion Agreement Accelerates Immunotherapies Targeting Toxic Forms of Amyloid Beta

ACI-24.060 is an anti-Abeta active immunotherapy candidate targeting Alzheimer's disease
Alzheimer’s Disease